Cargando…
Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839543/ https://www.ncbi.nlm.nih.gov/pubmed/30145186 http://dx.doi.org/10.1016/j.jaad.2018.08.017 |
_version_ | 1783467446834823168 |
---|---|
author | Chang, Anne Lynn S. Tran, Duy C. Cannon, John G. D. Li, Shufeng Jeng, Mark Patel, Roma Van der Bokke, Lindsay Pague, Alana Brotherton, Richard Rieger, Kerri E. Satpathy, Ansuman T. Yost, Kathryn E. Reddy, Sunil Sarin, Kavita Colevas, A. Dimitrios |
author_facet | Chang, Anne Lynn S. Tran, Duy C. Cannon, John G. D. Li, Shufeng Jeng, Mark Patel, Roma Van der Bokke, Lindsay Pague, Alana Brotherton, Richard Rieger, Kerri E. Satpathy, Ansuman T. Yost, Kathryn E. Reddy, Sunil Sarin, Kavita Colevas, A. Dimitrios |
author_sort | Chang, Anne Lynn S. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6839543 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-68395432019-11-08 Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study Chang, Anne Lynn S. Tran, Duy C. Cannon, John G. D. Li, Shufeng Jeng, Mark Patel, Roma Van der Bokke, Lindsay Pague, Alana Brotherton, Richard Rieger, Kerri E. Satpathy, Ansuman T. Yost, Kathryn E. Reddy, Sunil Sarin, Kavita Colevas, A. Dimitrios J Am Acad Dermatol Article 2018-08-24 2019-02 /pmc/articles/PMC6839543/ /pubmed/30145186 http://dx.doi.org/10.1016/j.jaad.2018.08.017 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Article Chang, Anne Lynn S. Tran, Duy C. Cannon, John G. D. Li, Shufeng Jeng, Mark Patel, Roma Van der Bokke, Lindsay Pague, Alana Brotherton, Richard Rieger, Kerri E. Satpathy, Ansuman T. Yost, Kathryn E. Reddy, Sunil Sarin, Kavita Colevas, A. Dimitrios Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study |
title | Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study |
title_full | Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study |
title_fullStr | Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study |
title_full_unstemmed | Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study |
title_short | Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study |
title_sort | pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839543/ https://www.ncbi.nlm.nih.gov/pubmed/30145186 http://dx.doi.org/10.1016/j.jaad.2018.08.017 |
work_keys_str_mv | AT changannelynns pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT tranduyc pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT cannonjohngd pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT lishufeng pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT jengmark pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT patelroma pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT vanderbokkelindsay pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT paguealana pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT brothertonrichard pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT riegerkerrie pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT satpathyansumant pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT yostkathryne pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT reddysunil pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT sarinkavita pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy AT colevasadimitrios pembrolizumabforadvancedbasalcellcarcinomaaninvestigatorinitiatedproofofconceptstudy |